5 RADNOR CORPORATE CENTER SUITE 500, RADNOR, PA
Completes Acquisition of Marinus Pharmaceuticals
Immedica to Acquire Biopharmaceutical Company
News, Material Contracts
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Investor Presentation
Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives
Q3
Q2
Q1
FY 2023
FY 2022
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership